InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Wan Mark A, 董事. Officer active across 2 companies, notably Acelrx Pharmaceuticals INC. In total, 5 filings have been recorded. History available since 17 June 2021. The latest transaction was disclosed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wan Mark A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
4,267 股0Common StockSEC:0001190472-25-000005:0
2,174 股0Common StockSEC:0001415889-24-018071:0
581 股0Common StockSEC:0001209191-23-058486:0
15,500 股0Common StockSEC:0001209191-22-042305:0
10,000 股0Common StockSEC:0001209191-21-041584:0
5 条申报中的 5 条
About Wan Mark A
Mark A. Wan is a Board Member at AcelRx Pharmaceuticals Inc. He provides valuable expertise to the board, contributing to the strategy and governance of the company. His experience in the pharmaceutical sector is an asset to AcelRx.
